1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 4,940 | 5,750 | 07.01. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 26.11.25 | Elekta AB reports Q2 results | 10 | Seeking Alpha | ||
| 26.11.25 | Elekta AB Non-GAAP EPS of SEK 0.64, revenue of SEK 4.07B; reaffirms FY outlook | 7 | Seeking Alpha | ||
| ELEKTA AB ADR Aktie jetzt für 0€ handeln | |||||
| 26.11.25 | Elekta AB: Second quarter, August-October 2025/26 | 332 | GlobeNewswire (Europe) | Second quarterIn constant exchange rates, net sales increased by 1 percent mainly driven by Europe. Reported sales in SEK decreased by 6 percent amounting to SEK 4,070 M (4,341).The book-to-bill ratio... ► Artikel lesen | |
| 06.11.25 | Elekta deepens presence in China with manufacturing and R&D assets | 9 | China Daily | ||
| 29.09.25 | Elekta AB: Study shows MRI-guided adaptive radiotherapy with Elekta Unity improves patient-reported urinary symptoms in men with prostate cancer | 375 | GlobeNewswire (Europe) | Data from an international registry confirms that tracking changes in prostate anatomy and adjusting radiation at each treatment session can lead to better long-term quality of life
SAN FRANCISCO -... ► Artikel lesen | |
| 25.09.25 | Elekta AB: Elekta marks two millionth patient treated with Leksell Gamma Knife radiosurgery | 198 | GlobeNewswire (Europe) | STOCKHOLM - Elekta (EKTA-B.ST) today announces that more than two million patients worldwide have now received Leksell Gamma Knife® radiosurgery. The two millionth treatment was recently carried out... ► Artikel lesen | |
| 08.09.25 | Dividendenbekanntmachungen (08.09.2025) | 8.156 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALPHABET INC CDR CA02080K1049 0,0341 CAD 0,0211 EUR ALPHABET INC CL A US02079K3059 0,21 USD 0,1791 EUR ALPHABET INC CL C US02079K1079 0... ► Artikel lesen | |
| 08.09.25 | Elekta Names Klara Eiritz Next CFO As Hägglöv Departs | 4 | RTTNews | ||
| 04.09.25 | Elekta AB: Report from the Annual General Meeting 2025 of Elekta | 348 | GlobeNewswire (Europe) | Elekta AB (publ) has held its Annual General Meeting on September 4, 2025. The statement at the Meeting from the President and CEO will be available on Elekta's website, www.elekta.com. Documents from... ► Artikel lesen | |
| 03.09.25 | UBS initiates Elekta at "sell," cites slowing radiotherapy market and 30% downside | 11 | Investing.com | ||
| 03.09.25 | UBS initiates Elekta stock with Sell rating, citing market headwinds | 1 | Investing.com | ||
| 28.08.25 | Elekta AB: Interim report, First quarter May-July 2025/26 | 436 | GlobeNewswire (Europe) | First quarterIn constant exchange rates, net sales increased by 3 percent driven by Europe. Reported sales in SEK decreased by 5 percent amounting to SEK 3,646 M (3,825).Book-to-bill ratio of 1.05 (1.10)... ► Artikel lesen | |
| 29.07.25 | S&P revises Elekta AB outlook to negative amid elevated leverage | 33 | Investing.com | ||
| 23.07.25 | Elekta wins expanded FDA nod for Gamma Knife radiosurgery system | 4 | MassDevice | ||
| 23.07.25 | Elekta's Gamma Knife Gains FDA Clearance For Drug-Resistant Temporal Lobe Epilepsy | 1 | RTTNews | ||
| 23.07.25 | Elekta AB: Elekta receives U.S. FDA 510(k) clearance for its Gamma Knife radiosurgery system to treat patients with refractory, drug-resistant mesial temporal lobe epilepsy | 356 | GlobeNewswire (Europe) | New indication expands treatment options for neurosurgeons managing complex epilepsy cases
ATLANTA - Elekta (EKTA-B.ST) today announced that it has received U.S. Food and Drug Administration (FDA) 510(k)... ► Artikel lesen | |
| 09.06.25 | Elekta AB: Elekta appoints Jakob Just-Bomholt as new President and CEO | 468 | GlobeNewswire (Europe) | STOCKHOLM - Elekta (EKTA-B.ST) announced today the appointment by the Board of Directors of Jakob Just-Bomholt as its new President and Chief Executive Officer, effective September 1, 2025.
Jakob, a... ► Artikel lesen | |
| 28.05.25 | Elekta AB: Year-end report May-April 2024/25 | 464 | GlobeNewswire (Europe) | Fourth quarterIn constant exchange rates, net sales increased by 6 percent mainly driven by Europe and APAC. Reported sales increased by 3 percent amounting to SEK 5,156 M (5,023).Book-to-bill ratio... ► Artikel lesen | |
| 03.05.25 | Elekta AB: Clinical trial shows more precise radiotherapy using Elekta Unity MR-Linac preserves sexual function in men with prostate cancer | 331 | GlobeNewswire (Europe) | ERECT trial used MR-guidance to spare nerves and blood vessels essential for achieving and maintaining an erection
VIENNA - Elekta (EKTA-B.ST) today announced that use of its 1.5T Elekta Unity MR-Linac... ► Artikel lesen | |
| 07.03.25 | Dividendenbekanntmachungen (07.03.2025) | 19.245 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACUSHNET HOLDINGS CORP US0050981085 0,235 USD 0,2177 EUR AEW UK REIT PLC GB00BWD24154 0,02 GBP EUR AMERISAFE INC US03071H1005 0... ► Artikel lesen |
1 2 Weiter >>
22 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FAMICORD | 6,050 | +1,68 % | EQS-News: FamiCord AG beschleunigt profitables Wachstum im dritten Quartal 2025 und stärkt Qualität und Visibilität der Umsatzentwicklung | EQS-News: FamiCord AG
/ Schlagwort(e): 9-Monatszahlen
FamiCord AG beschleunigt profitables Wachstum im dritten Quartal 2025 und stärkt Qualität und Visibilität der Umsatzentwicklung... ► Artikel lesen | |
| SPINEWAY | 0,188 | 0,00 % | Spineway: Revenue growth in the third quarter | Ecully, October 14, 2025 - 6:30 p.m. SPINEWAYRevenue growth in the third quarter In thousands of euros20252024Change as a %Q3 revenue3,0452,575 +18%Q2 revenue2,7453,465-21% Q1 revenue2,8283,070-8%9M... ► Artikel lesen | |
| PETMED EXPRESS | 3,001 | -1,90 % | PetMed Express, Inc.: PetMed Express Comments on Unsolicited and Non-Binding Acquisition Proposal Received From SilverCape Investments Limited | DELRAY BEACH, Fla., Dec. 11, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the "Company" or "PetMeds"), today confirmed that it has... ► Artikel lesen | |
| QUIDELORTHO | 27,400 | -1,44 % | QuidelOrtho Corporation: QuidelOrtho Reports Third Quarter 2025 Financial Results | ? Total revenue of $700 million; excluding COVID-19 and Donor Screening, revenue grew mid-single digits, demonstrating solid underlying growth and momentum ? ... ► Artikel lesen | |
| ELEKTA | 5,440 | +2,06 % | Elekta AB: Second quarter, August-October 2025/26 | Second quarterIn constant exchange rates, net sales increased by 1 percent mainly driven by Europe. Reported sales in SEK decreased by 6 percent amounting to SEK 4,070 M (4,341).The book-to-bill ratio... ► Artikel lesen | |
| STAAR SURGICAL | 19,045 | -0,13 % | Alcon wird US-Unternehmen Staar Surgical nicht übernehmen | VERNIER (dpa-AFX) - Der Augenheilkunde-Konzern Alcon wird das US-Unternehmen Staar Surgical nicht übernehmen. Die Gegenwehr aus Aktionärskreisen von Staar war letztendlich zu groß. Nach mehrmaligem... ► Artikel lesen | |
| TELEFLEX | 108,00 | +0,93 % | Teleflex To Divest Acute Care, Interventional Urology, OEM Businesses For $2.03 Bln | WASHINGTON (dpa-AFX) - Teleflex Inc. (TFX), a medical technologies provider, Tuesday announced that it has agreed to sell its Acute Care, Interventional Urology to Intersurgical Ltd and OEM... ► Artikel lesen | |
| NOVACYT | 0,409 | +1,11 % | Novacyt S.A. - Liquidity Agreement Monthly Update and TVR | ||
| M3 INC | 11,400 | +0,88 % | Der Anteilsschein von M3 heute schwach: Kurs rutscht deutlich ab! (12,70 €) | Die Aktie von M3 zählt heute zu den großen Verlierern am Aktienmarkt. Der Kurs des Anteilsscheins sackt kräftig ab. Zu den größten Verlierern des Tages an der Börse zählt derzeit die Aktie von M3. Im... ► Artikel lesen | |
| INSPIRE MEDICAL SYSTEMS | 83,56 | +0,41 % | Faruqi & Faruqi LLP: SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Inspire Medical Systems Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 5, 2026 | Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inspire Medical To Contact Him Directly To Discuss Their OptionsIf you purchased... ► Artikel lesen | |
| AMBEA | 13,210 | +1,46 % | Ambea AB: Ambea further strengthens its offering within child and youth care through an acquisition in Finland | Ambea, through its Finnish business area Validia, has entered into an agreement to acquire Terveystalo Sauma Lastensuojelupalvelut Oy. The acquisition relates to child protection and family care services... ► Artikel lesen | |
| SHIP HEALTHCARE | 14,100 | 0,00 % | Ship Healthcare im Geschäftsjahr 2025: Umsatz steigt um 7,5 %, Strategieplan "SHIP VISION 2030" vorgestellt | ||
| BUMRUNGRAD HOSPITAL | 4,100 | -0,49 % | Bumrungrad Launches "Smart Personalized HealthMatch" and "Biological Age" Revolutionizing Preventive Health Screening | ||
| MERCATOR MEDICAL | 9,490 | +3,49 % | Mercator Medical posts PLN 4.5 mln net profit in Q3 2025 - prelims | ||
| SIEMENS HEALTHINEERS | 46,310 | +0,46 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers auf "Hold" mit einem Kursziel von 46 Euro belassen. Er rechne damit, dass der Start in das neue Geschäftsjahr... ► Artikel lesen |
Das Unternehmen ELEKTA AB ADR kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 5,100 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ELEKTA AB ADR finden Sie auf Wallstreet Online.